Streetbeat News

Products Services

SYF

PatientNow, a cloud-based practice management solution, has partnered with Synchrony to offer CareCredit, a healthcare financing option, to aesthetic and cosmetic businesses. This partnership aims to provide these businesses with a tool to help their clients finance procedures and treatments.

Portfolio Pulse from Benzinga Newsdesk

January 30, 2024 | 2:20 pm

BIGC

Algolia, an AI search technology provider, has been named a Preferred Technology Partner by BigCommerce. FKA Brands has integrated Algolia's AI search with BigCommerce's platform, enhancing the shopping experience and achieving fast-time-to-value for customers.

Portfolio Pulse from Benzinga Newsdesk

January 30, 2024 | 2:19 pm

SHIP

Seanergy Maritime Holdings, through its subsidiary Seanergy Shipmanagement, has joined the SAFeCRAFT Project Consortium, which is EU funded. Seanergy will retrofit one of its Capesize vessels to use hydrogen for electric power generation and partial propulsion, aiming to reduce dependence on conventional fuels.

Portfolio Pulse from Benzinga Newsdesk

January 30, 2024 | 2:14 pm

GILD

Kite, a subsidiary of Gilead Sciences, has received FDA approval for a manufacturing process change for Yescarta CAR T-cell therapy. This change is expected to reduce the median turnaround time for treatment in the U.S. from 16 days to 14 days, maintaining Kite's position as a leader in overall turnaround time and reliability. The reduction in time to treatment is particularly significant for patients requiring CAR T-cell therapy.

Portfolio Pulse from Benzinga Newsdesk

January 30, 2024 | 2:10 pm

BOKF

MA

Mastercard and BOK Financial Corporation have expanded their agreement, making Mastercard the exclusive payments network for BOK Financial's debit and commercial portfolios. This deal is expected to enhance the customer experience and streamline operations for BOK Financial.

Portfolio Pulse from Benzinga Newsdesk

January 30, 2024 | 2:07 pm

RVSN

Rail Vision has unveiled a new AI computer designed to enhance railway safety and prevent accidents through high-performance, real-time AI deep learning inferencing.

Portfolio Pulse from Benzinga Newsdesk

January 30, 2024 | 2:05 pm

AUDC

AudioCodes and Kramer have announced a partnership to enhance the Microsoft Teams Meeting Experience by integrating AudioCodes' Microsoft Teams Room solutions, management tools, and AI-powered meeting analytics with Kramer's audio-visual solutions. This collaboration aims to improve user experience and productivity in meetings and provides system integrators with a comprehensive solution for Microsoft Teams meeting spaces.

Portfolio Pulse from Benzinga Newsdesk

January 30, 2024 | 2:05 pm

MSFT

Microsoft CEO Satya Nadella has expressed concerns over AI-generated explicit deepfakes of Taylor Swift, calling the situation 'alarming and terrible.' In an NBC Nightly News interview, he highlighted the need for tech companies to implement safeguards and proposed a global agreement for content regulation. The controversy underscores the misuse of AI technology, with incidents of nonconsensual explicit images spreading on social media. Microsoft's Designer image generator is speculated to have been used to create such images, although this is unconfirmed.

Portfolio Pulse from Rounak Jain

January 30, 2024 | 2:04 pm

INTC

MSFT

On the 17th anniversary of Windows Vista's release, a reflection on Microsoft's stock performance reveals a 1,225% increase from $30.48 on Jan. 30, 2007, to $403.93 today. A $1,000 investment in Microsoft then would be worth $13,252 now, outperforming similar investments in Nasdaq and S&P 500 index funds. Microsoft continues to innovate, integrating AI into Windows with the AI-powered Copilot, and is optimistic about the PC market's future, supported by data from Counterpoint Research and IDC. Intel Corp. also anticipates a PC market revival.

Portfolio Pulse from Rounak Jain

January 30, 2024 | 2:03 pm

PSNL

Personalis, Inc. has announced a partnership with ClearNote Health to offer ClearNote's patented Epigenomic Platform to its biopharmaceutical partners. This collaboration aims to enhance Personalis' offerings in the precision medicine space by integrating ClearNote's advanced epigenomic technology, which could potentially lead to more personalized healthcare solutions.

Portfolio Pulse from Benzinga Newsdesk

January 30, 2024 | 2:01 pm